Inflammatory IL-15 is required for optimal memory T cell responses

Journal of Clinical Investigation

Volumn 125, Issue 9, 2015, Pages 3477-3490

  Richer, Martin J ^a   Pewe, Lecia L ^a   Hancox, Lisa S ^a   Hartwig, Stacey M ^a   Varga, Steven M ^a,b,c   Harty, John T ^a,b,c  

^a UNIVERSITY OF IOWA   (United States)

^b Microbiome and Disease Tolerance Centre   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON REGULATORY FACTOR 1; INTERLEUKIN 15; MAMMALIAN TARGET OF RAPAMYCIN; T LYMPHOCYTE RECEPTOR; IL15 PROTEIN, HUMAN; INTERFERON; MECHANISTIC TARGET OF RAPAMYCIN COMPLEX 1; MULTIPROTEIN COMPLEX; TARGET OF RAPAMYCIN KINASE;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ARTICLE; CD8+ T LYMPHOCYTE; CELL CYCLE; CELL CYCLE M PHASE; CELL CYCLE PHASE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RESPONSE; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; IN VITRO STUDY; MEMORY T LYMPHOCYTE; MITOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEADY STATE; UPREGULATION; VIRUS INFECTION; ANIMAL; CELL DIVISION; CYTOLOGY; GENETICS; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; KNOCKOUT MOUSE;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL DIVISION; HUMANS; IMMUNOLOGIC MEMORY; INTERFERON TYPE I; INTERLEUKIN-15; MICE; MICE, KNOCKOUT; MULTIPROTEIN COMPLEXES; TOR SERINE-THREONINE KINASES;

EID: 84941614968     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI81261     Document Type: Article

References (47)

1. Cho BK, Wang C, Sugawa S, Eisen HN, Chen J. Functional differences between memory and naive CD8 T cells. Proc Natl Acad Sci U S A. 1999;96 (6) :2976-2981.
2. Barber DL, Wherry EJ, Ahmed R. Cutting edge: rapid in vivo killing by memory CD8 T cells. J Immunol. 2003;171 (1) :27-31.
3. Whitmire JK, Eam B, Whitton JL. Tentative T cells: memory cells are quick to respond, but slow to divide. PLoS Pathog. 2008;4 (4) :e1000041.
4. Veiga-Fernandes H, Walter U, Bourgeois C, McLean A, Rocha B. Response of naive and memory CD8+ T cells to antigen stimulation in vivo. Nat Immunol. 2000;1 (1) :47-53.
5. Veiga-Fernandes H, Rocha B. High expression of active CDK6 in the cytoplasm of CD8 memory cells favors rapid division. Nat Immunol. 2004;5 (1) :31-37.
6. Zimmermann C, Prevost-Blondel A, Blaser C, Pircher H. Kinetics of the response of naive and memory CD8 T cells to antigen: similarities and differences. Eur J Immunol. 1999;29 (1) :284-290.
7. Allam A, et al. The CD8+ memory T-cell state of readiness is actively maintained and reversible. Blood. 2009;114 (10) :2121-2130.
8. Mehlhop-Williams ER, Bevan MJ. Memory CD8+ T cells exhibit increased antigen threshold requirements for recall proliferation. J Exp Med. 2014;211 (2) :345-356.
9. Martin MD, Condotta SA, Harty JT, Badovinac VP. Population dynamics of naive and memory CD8 T cell responses after antigen stimulations in vivo. J Immunol. 2012;188 (3) :1255-1265.
10. Ely KH, Cauley LS, Roberts AD, Brennan JW, Cookenham T, Woodland DL. Nonspecific recruitment of memory CD8+ T cells to the lung airways during respiratory virus infections. J Immunol. 2003;170 (3) :1423-1429.
11. Nolz JC, Harty JT. IL-15 regulates memory CD8+ T cell O-glycan synthesis and affects trafficking. J Clin Invest. 2014;124 (3) :1013-1026.
12. Richer MJ, Nolz JC, Harty JT. Pathogen-specific inflammatory milieux tune the antigen sensitivity of CD8 (+) T cells by enhancing T cell receptor signaling. Immunity. 2013;38 (1) :140-152.
13. Kim SK, Brehm MA, Welsh RM, Selin LK. Dynamics of memory T cell proliferation under conditions of heterologous immunity and bystander stimulation. J Immunol. 2002;169 (1) :90-98.
14. Masopust D, Murali-Krishna K, Ahmed R. Quantitating the magnitude of the lymphocytic choriomeningitis virus-specific CD8 T-cell response: it is even bigger than we thought. J Virol. 2007;81 (4) :2002-2011.
15. Raue HP, Beadling C, Haun J, Slifka MK. Cytokine-mediated programmed proliferation of virus-specific CD8 (+) memory T cells. Immunity. 2013;38 (1) :131-139.
16. Tough DF, Borrow P, Sprent J. Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science. 1996;272 (5270) :1947-1950.
17. Zhang X, Sun S, Hwang I, Tough DF, Sprent J. Potent and selective stimulation of memoryphenotype CD8+ T cells in vivo by IL-15. Immunity. 1998;8 (5) :591-599.
18. Schluns KS, Williams K, Ma A, Zheng XX, Lefrancois L. Cutting edge: requirement for IL-15 in the generation of primary and memory antigen-specific CD8 T cells. J Immunol. 2002;168 (10) :4827-4831.
19. Becker TC, et al. Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells. J Exp Med. 2002;195 (12) :1541-1548.
20. Goldrath AW, et al. Cytokine requirements for acute and Basal homeostatic proliferation of naive and memory CD8+ T cells. J Exp Med. 2002;195 (12) :1515-1522.
21. Ku CC, Murakami M, Sakamoto A, Kappler J, Marrack P. Control of homeostasis of CD8+ memory T cells by opposing cytokines. Science. 2000;288 (5466) :675-678.
22. Mogensen TH, Paludan SR. Molecular pathways in virus-induced cytokine production. Microbiol Mol Biol Rev. 2001;65 (1) :131-150.
23. Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4 (1) :44-57.
24. Huang DW, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009;37 (1) :1-13.
25. Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol. 2000;182 (3) :311-322.
26. Biron CA. Initial and innate responses to viral infections-pattern setting in immunity or disease. Curr Opin Microbiol. 1999;2 (4) :374-381.
27. Nguyen KB, et al. Coordinated and distinct roles for IFN-αβ, IL-12, and IL-15 regulation of NK cell responses to viral infection. J Immunol. 2002;169 (8) :4279-4287.
28. Mattei F, Schiavoni G, Belardelli F, Tough DF. IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation. J Immunol. 2001;167 (3) :1179-1187.
29. Waldmann TA. The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design. Nat Rev Immunol. 2006;6 (8) :595-601.
30. Waickman AT, Powell JD. mTOR, metabolism, and the regulation of T-cell differentiation and function. Immunol Rev. 2012;249 (1) :43-58.
31. Song J, Salek-Ardakani S, So T, Croft M. The kinases aurora B and mTOR regulate the G1-S cell cycle progression of T lymphocytes. Nat Immunol. 2007;8 (1) :64-73.
32. Marcais A, et al. The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells. Nat Immunol. 2014;15 (8) :749-757.
33. Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell. 2012;149 (2) :274-293.
34. Kohlmeier JE, Cookenham T, Roberts AD, Miller SC, Woodland DL. Type I interferons regulate cytolytic activity of memory CD8 (+) T cells in the lung airways during respiratory virus challenge. Immunity. 2010;33 (1) :96-105.
35. Kim DH, et al. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell. 2002;110 (2) :163-175.
36. Fingar DC, Richardson CJ, Tee AR, Cheatham L, Tsou C, Blenis J. mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E. Mol Cell Biol. 2004;24 (1) :200-216.
37. Nolz JC, Harty JT. Protective capacity of memory CD8+ T cells is dictated by antigen exposure history and nature of the infection. Immunity. 2011;34 (5) :781-793.
38. Boyman O, Sprent J. The role of interleukin-2 during homeostasis and activation of the immune system. Nat Rev Immunol. 2012;12 (3) :180-190.
39. Wirth TC, et al. Repetitive antigen stimulation induces stepwise transcriptome diversification but preserves a core signature of memory CD8 (+) T cell differentiation. Immunity. 2010;33 (1) :128-140.
40. Selin LK, Varga SM, Wong IC, Welsh RM. Protective heterologous antiviral immunity and enhanced immunopathogenesis mediated by memory T cell populations. J Exp Med. 1998;188 (9) :1705-1715.
41. Welsh RM, Che JW, Brehm MA, Selin LK. Heterologous immunity between viruses. Immunol Rev. 2010;235 (1) :244-266.
42. Araki K, et al. mTOR regulates memory CD8 T-cell differentiation. Nature. 2009;460 (7251) :108-112.
43. Hogquist KA, Jameson SC, Heath WR, Howard JL, Bevan MJ, Carbone FR. T cell receptor antagonist peptides induce positive selection. Cell. 1994;76 (1) :17-27.
44. Pircher H, et al. Characterization of virus-specific cytotoxic T cell clones from allogeneic bone marrow chimeras. Eur J Immunol. 1987;17 (2) :159-166.
45. Slifka MK, Whitton JL. Functional avidity maturation of CD8 (+) T cells without selection of higher affinity TCR. Nat Immunol. 2001;2 (8) :711-717.
46. Varga SM, Selin LK, Welsh RM. Independent regulation of lymphocytic choriomeningitis virusspecific T cell memory pools: relative stability of CD4 memory under conditions of CD8 memory T cell loss. J Immunol. 2001;166 (3) :1554-1561.
47. Starbeck-Miller GR, Xue HH, Harty JT. IL-12 and type I interferon prolong the division of activated CD8 T cells by maintaining high-Affinity IL-2 signaling in vivo. J Exp Med. 2014;211 (1) :105-120.